nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2C19—prostate cancer	0.162	0.611	CbGaD
Fosphenytoin—CYP3A4—prostate cancer	0.103	0.389	CbGaD
Fosphenytoin—ALB—Abiraterone—prostate cancer	0.0308	0.0633	CbGbCtD
Fosphenytoin—CYP2C8—Nilutamide—prostate cancer	0.0287	0.0591	CbGbCtD
Fosphenytoin—CYP2C19—Bicalutamide—prostate cancer	0.0241	0.0495	CbGbCtD
Fosphenytoin—CYP2C19—Nilutamide—prostate cancer	0.0241	0.0495	CbGbCtD
Fosphenytoin—CYP2C8—Abiraterone—prostate cancer	0.0238	0.0489	CbGbCtD
Fosphenytoin—CYP2B6—Estrone—prostate cancer	0.0227	0.0467	CbGbCtD
Fosphenytoin—ALB—Estrone—prostate cancer	0.0223	0.0458	CbGbCtD
Fosphenytoin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0222	0.0456	CbGbCtD
Fosphenytoin—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0203	0.0416	CbGbCtD
Fosphenytoin—CYP2C9—Bicalutamide—prostate cancer	0.02	0.0412	CbGbCtD
Fosphenytoin—CYP2C9—Nilutamide—prostate cancer	0.02	0.0412	CbGbCtD
Fosphenytoin—CYP2C19—Flutamide—prostate cancer	0.02	0.0411	CbGbCtD
Fosphenytoin—CYP2C8—Cabazitaxel—prostate cancer	0.0176	0.0362	CbGbCtD
Fosphenytoin—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0153	0.0315	CbGbCtD
Fosphenytoin—ALB—Estradiol—prostate cancer	0.0128	0.0263	CbGbCtD
Fosphenytoin—CYP2C9—Estrone—prostate cancer	0.012	0.0247	CbGbCtD
Fosphenytoin—CYP3A4—Bicalutamide—prostate cancer	0.0117	0.024	CbGbCtD
Fosphenytoin—ALB—Prednisone—prostate cancer	0.011	0.0226	CbGbCtD
Fosphenytoin—CYP3A4—Estramustine—prostate cancer	0.0108	0.0223	CbGbCtD
Fosphenytoin—CYP2C8—Estradiol—prostate cancer	0.00989	0.0203	CbGbCtD
Fosphenytoin—CYP3A4—Flutamide—prostate cancer	0.00966	0.0198	CbGbCtD
Fosphenytoin—CYP3A4—Abiraterone—prostate cancer	0.00966	0.0198	CbGbCtD
Fosphenytoin—CYP2C9—Capecitabine—prostate cancer	0.0091	0.0187	CbGbCtD
Fosphenytoin—CYP2C19—Estradiol—prostate cancer	0.0083	0.017	CbGbCtD
Fosphenytoin—CYP3A4—Cabazitaxel—prostate cancer	0.00714	0.0147	CbGbCtD
Fosphenytoin—CYP2C19—Prednisone—prostate cancer	0.00713	0.0147	CbGbCtD
Fosphenytoin—CYP3A4—Estrone—prostate cancer	0.00698	0.0143	CbGbCtD
Fosphenytoin—CYP2C9—Estradiol—prostate cancer	0.0069	0.0142	CbGbCtD
Fosphenytoin—CYP2C8—Etoposide—prostate cancer	0.00646	0.0133	CbGbCtD
Fosphenytoin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00622	0.0128	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—prostate cancer	0.00581	0.0119	CbGbCtD
Fosphenytoin—CYP3A4—Conjugated Estrogens—prostate cancer	0.00457	0.00939	CbGbCtD
Fosphenytoin—CYP3A4—Mitoxantrone—prostate cancer	0.00415	0.00853	CbGbCtD
Fosphenytoin—CYP3A4—Estradiol—prostate cancer	0.00401	0.00824	CbGbCtD
Fosphenytoin—CYP3A4—Prednisone—prostate cancer	0.00345	0.00709	CbGbCtD
Fosphenytoin—CYP3A4—Etoposide—prostate cancer	0.00262	0.00538	CbGbCtD
Fosphenytoin—CYP3A4—Docetaxel—prostate cancer	0.0024	0.00492	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—prostate cancer	0.00179	0.00367	CbGbCtD
Fosphenytoin—Phenytoin—CYP2C18—prostate cancer	0.000287	0.185	CrCbGaD
Fosphenytoin—Modafinil—CYP3A5—prostate cancer	0.000213	0.137	CrCbGaD
Fosphenytoin—Phenytoin—CYP3A5—prostate cancer	0.000189	0.122	CrCbGaD
Fosphenytoin—Methylphenobarbital—CYP2C19—prostate cancer	0.000183	0.118	CrCbGaD
Fosphenytoin—Modafinil—CYP2C19—prostate cancer	0.000145	0.0934	CrCbGaD
Fosphenytoin—Phenytoin—CYP2C19—prostate cancer	0.000129	0.0828	CrCbGaD
Fosphenytoin—Phenylbutazone—CYP3A4—prostate cancer	0.000118	0.0758	CrCbGaD
Fosphenytoin—Phenylbutazone—PTGS2—prostate cancer	0.000115	0.0742	CrCbGaD
Fosphenytoin—Modafinil—CYP3A4—prostate cancer	9.23e-05	0.0594	CrCbGaD
Fosphenytoin—Phenytoin—CYP3A4—prostate cancer	8.19e-05	0.0527	CrCbGaD
Fosphenytoin—Asthenia—Mitoxantrone—prostate cancer	4.21e-05	0.000266	CcSEcCtD
Fosphenytoin—Cough—Capecitabine—prostate cancer	4.2e-05	0.000265	CcSEcCtD
Fosphenytoin—Constipation—Etoposide—prostate cancer	4.18e-05	0.000264	CcSEcCtD
Fosphenytoin—Conjunctivitis—Epirubicin—prostate cancer	4.17e-05	0.000263	CcSEcCtD
Fosphenytoin—Dizziness—Estradiol—prostate cancer	4.17e-05	0.000263	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—prostate cancer	4.17e-05	0.000263	CcSEcCtD
Fosphenytoin—Hypertension—Capecitabine—prostate cancer	4.16e-05	0.000262	CcSEcCtD
Fosphenytoin—Dry mouth—Docetaxel—prostate cancer	4.14e-05	0.000261	CcSEcCtD
Fosphenytoin—Sweating—Epirubicin—prostate cancer	4.12e-05	0.00026	CcSEcCtD
Fosphenytoin—Myalgia—Capecitabine—prostate cancer	4.1e-05	0.000259	CcSEcCtD
Fosphenytoin—Arthralgia—Capecitabine—prostate cancer	4.1e-05	0.000259	CcSEcCtD
Fosphenytoin—Confusional state—Docetaxel—prostate cancer	4.09e-05	0.000258	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—prostate cancer	4.07e-05	0.000257	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Docetaxel—prostate cancer	4.06e-05	0.000256	CcSEcCtD
Fosphenytoin—Discomfort—Capecitabine—prostate cancer	4.05e-05	0.000256	CcSEcCtD
Fosphenytoin—Epistaxis—Epirubicin—prostate cancer	4.05e-05	0.000255	CcSEcCtD
Fosphenytoin—Infection—Docetaxel—prostate cancer	4.03e-05	0.000254	CcSEcCtD
Fosphenytoin—Sinusitis—Epirubicin—prostate cancer	4.03e-05	0.000254	CcSEcCtD
Fosphenytoin—Feeling abnormal—Etoposide—prostate cancer	4.02e-05	0.000254	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—prostate cancer	4.02e-05	0.000254	CcSEcCtD
Fosphenytoin—Diarrhoea—Mitoxantrone—prostate cancer	4.02e-05	0.000253	CcSEcCtD
Fosphenytoin—Dry mouth—Capecitabine—prostate cancer	4.01e-05	0.000253	CcSEcCtD
Fosphenytoin—Vomiting—Estradiol—prostate cancer	4.01e-05	0.000253	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—prostate cancer	4e-05	0.000252	CcSEcCtD
Fosphenytoin—Shock—Docetaxel—prostate cancer	3.99e-05	0.000252	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Prednisone—prostate cancer	3.98e-05	0.000251	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Docetaxel—prostate cancer	3.97e-05	0.000251	CcSEcCtD
Fosphenytoin—Rash—Estradiol—prostate cancer	3.97e-05	0.000251	CcSEcCtD
Fosphenytoin—Dermatitis—Estradiol—prostate cancer	3.97e-05	0.00025	CcSEcCtD
Fosphenytoin—Anaemia—Prednisone—prostate cancer	3.96e-05	0.00025	CcSEcCtD
Fosphenytoin—Confusional state—Capecitabine—prostate cancer	3.96e-05	0.00025	CcSEcCtD
Fosphenytoin—Tachycardia—Docetaxel—prostate cancer	3.96e-05	0.00025	CcSEcCtD
Fosphenytoin—Headache—Estradiol—prostate cancer	3.95e-05	0.000249	CcSEcCtD
Fosphenytoin—Agitation—Prednisone—prostate cancer	3.94e-05	0.000249	CcSEcCtD
Fosphenytoin—Bradycardia—Epirubicin—prostate cancer	3.92e-05	0.000248	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—prostate cancer	3.9e-05	0.000246	CcSEcCtD
Fosphenytoin—Infection—Capecitabine—prostate cancer	3.9e-05	0.000246	CcSEcCtD
Fosphenytoin—Urticaria—Etoposide—prostate cancer	3.88e-05	0.000245	CcSEcCtD
Fosphenytoin—Anorexia—Docetaxel—prostate cancer	3.87e-05	0.000244	CcSEcCtD
Fosphenytoin—Malaise—Prednisone—prostate cancer	3.87e-05	0.000244	CcSEcCtD
Fosphenytoin—Shock—Capecitabine—prostate cancer	3.87e-05	0.000244	CcSEcCtD
Fosphenytoin—Rhinitis—Epirubicin—prostate cancer	3.86e-05	0.000244	CcSEcCtD
Fosphenytoin—Body temperature increased—Etoposide—prostate cancer	3.86e-05	0.000244	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—prostate cancer	3.86e-05	0.000244	CcSEcCtD
Fosphenytoin—Vertigo—Prednisone—prostate cancer	3.85e-05	0.000243	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Capecitabine—prostate cancer	3.85e-05	0.000243	CcSEcCtD
Fosphenytoin—Syncope—Prednisone—prostate cancer	3.85e-05	0.000243	CcSEcCtD
Fosphenytoin—Tachycardia—Capecitabine—prostate cancer	3.84e-05	0.000242	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Epirubicin—prostate cancer	3.83e-05	0.000242	CcSEcCtD
Fosphenytoin—Pharyngitis—Epirubicin—prostate cancer	3.82e-05	0.000241	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—prostate cancer	3.81e-05	0.00024	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Capecitabine—prostate cancer	3.8e-05	0.00024	CcSEcCtD
Fosphenytoin—Hypotension—Docetaxel—prostate cancer	3.79e-05	0.000239	CcSEcCtD
Fosphenytoin—Loss of consciousness—Prednisone—prostate cancer	3.77e-05	0.000238	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—prostate cancer	3.75e-05	0.000236	CcSEcCtD
Fosphenytoin—Anorexia—Capecitabine—prostate cancer	3.75e-05	0.000236	CcSEcCtD
Fosphenytoin—Nausea—Estradiol—prostate cancer	3.74e-05	0.000236	CcSEcCtD
Fosphenytoin—Vomiting—Mitoxantrone—prostate cancer	3.73e-05	0.000236	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—prostate cancer	3.73e-05	0.000235	CcSEcCtD
Fosphenytoin—Convulsion—Prednisone—prostate cancer	3.72e-05	0.000234	CcSEcCtD
Fosphenytoin—Hypertension—Prednisone—prostate cancer	3.7e-05	0.000234	CcSEcCtD
Fosphenytoin—Rash—Mitoxantrone—prostate cancer	3.7e-05	0.000234	CcSEcCtD
Fosphenytoin—Dermatitis—Mitoxantrone—prostate cancer	3.7e-05	0.000233	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.7e-05	0.000233	CcSEcCtD
Fosphenytoin—Headache—Mitoxantrone—prostate cancer	3.68e-05	0.000232	CcSEcCtD
Fosphenytoin—Hypotension—Capecitabine—prostate cancer	3.67e-05	0.000232	CcSEcCtD
Fosphenytoin—Insomnia—Docetaxel—prostate cancer	3.67e-05	0.000232	CcSEcCtD
Fosphenytoin—Arthralgia—Prednisone—prostate cancer	3.65e-05	0.00023	CcSEcCtD
Fosphenytoin—Myalgia—Prednisone—prostate cancer	3.65e-05	0.00023	CcSEcCtD
Fosphenytoin—Paraesthesia—Docetaxel—prostate cancer	3.64e-05	0.00023	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—prostate cancer	3.63e-05	0.000229	CcSEcCtD
Fosphenytoin—Dyspnoea—Docetaxel—prostate cancer	3.62e-05	0.000228	CcSEcCtD
Fosphenytoin—Somnolence—Docetaxel—prostate cancer	3.61e-05	0.000228	CcSEcCtD
Fosphenytoin—Discomfort—Prednisone—prostate cancer	3.61e-05	0.000228	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—prostate cancer	3.59e-05	0.000227	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.58e-05	0.000226	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—prostate cancer	3.57e-05	0.000226	CcSEcCtD
Fosphenytoin—Dyspepsia—Docetaxel—prostate cancer	3.57e-05	0.000225	CcSEcCtD
Fosphenytoin—Insomnia—Capecitabine—prostate cancer	3.55e-05	0.000224	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—prostate cancer	3.55e-05	0.000224	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—prostate cancer	3.54e-05	0.000223	CcSEcCtD
Fosphenytoin—Paraesthesia—Capecitabine—prostate cancer	3.53e-05	0.000223	CcSEcCtD
Fosphenytoin—Decreased appetite—Docetaxel—prostate cancer	3.53e-05	0.000223	CcSEcCtD
Fosphenytoin—Asthenia—Etoposide—prostate cancer	3.5e-05	0.000221	CcSEcCtD
Fosphenytoin—Dyspnoea—Capecitabine—prostate cancer	3.5e-05	0.000221	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Prednisone—prostate cancer	3.5e-05	0.000221	CcSEcCtD
Fosphenytoin—Nausea—Mitoxantrone—prostate cancer	3.49e-05	0.00022	CcSEcCtD
Fosphenytoin—Infection—Prednisone—prostate cancer	3.48e-05	0.000219	CcSEcCtD
Fosphenytoin—Constipation—Docetaxel—prostate cancer	3.47e-05	0.000219	CcSEcCtD
Fosphenytoin—Dyspepsia—Capecitabine—prostate cancer	3.46e-05	0.000218	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—prostate cancer	3.46e-05	0.000218	CcSEcCtD
Fosphenytoin—Pruritus—Etoposide—prostate cancer	3.46e-05	0.000218	CcSEcCtD
Fosphenytoin—Shock—Prednisone—prostate cancer	3.44e-05	0.000217	CcSEcCtD
Fosphenytoin—Tachycardia—Prednisone—prostate cancer	3.42e-05	0.000216	CcSEcCtD
Fosphenytoin—Decreased appetite—Capecitabine—prostate cancer	3.42e-05	0.000216	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Prednisone—prostate cancer	3.38e-05	0.000214	CcSEcCtD
Fosphenytoin—Constipation—Capecitabine—prostate cancer	3.36e-05	0.000212	CcSEcCtD
Fosphenytoin—Feeling abnormal—Docetaxel—prostate cancer	3.34e-05	0.000211	CcSEcCtD
Fosphenytoin—Diarrhoea—Etoposide—prostate cancer	3.34e-05	0.000211	CcSEcCtD
Fosphenytoin—Anorexia—Prednisone—prostate cancer	3.34e-05	0.000211	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—prostate cancer	3.32e-05	0.00021	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—prostate cancer	3.31e-05	0.000209	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—prostate cancer	3.29e-05	0.000208	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—prostate cancer	3.29e-05	0.000207	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—prostate cancer	3.26e-05	0.000206	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—prostate cancer	3.24e-05	0.000205	CcSEcCtD
Fosphenytoin—Feeling abnormal—Capecitabine—prostate cancer	3.24e-05	0.000204	CcSEcCtD
Fosphenytoin—Dizziness—Etoposide—prostate cancer	3.23e-05	0.000204	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—prostate cancer	3.23e-05	0.000203	CcSEcCtD
Fosphenytoin—Body temperature increased—Docetaxel—prostate cancer	3.21e-05	0.000202	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—prostate cancer	3.2e-05	0.000202	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Prednisone—prostate cancer	3.19e-05	0.000201	CcSEcCtD
Fosphenytoin—Insomnia—Prednisone—prostate cancer	3.17e-05	0.0002	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisone—prostate cancer	3.14e-05	0.000198	CcSEcCtD
Fosphenytoin—Urticaria—Capecitabine—prostate cancer	3.12e-05	0.000197	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—prostate cancer	3.11e-05	0.000196	CcSEcCtD
Fosphenytoin—Body temperature increased—Capecitabine—prostate cancer	3.11e-05	0.000196	CcSEcCtD
Fosphenytoin—Vomiting—Etoposide—prostate cancer	3.11e-05	0.000196	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—prostate cancer	3.1e-05	0.000196	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—prostate cancer	3.08e-05	0.000195	CcSEcCtD
Fosphenytoin—Dyspepsia—Prednisone—prostate cancer	3.08e-05	0.000194	CcSEcCtD
Fosphenytoin—Rash—Etoposide—prostate cancer	3.08e-05	0.000194	CcSEcCtD
Fosphenytoin—Dermatitis—Etoposide—prostate cancer	3.08e-05	0.000194	CcSEcCtD
Fosphenytoin—Headache—Etoposide—prostate cancer	3.06e-05	0.000193	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—prostate cancer	3.06e-05	0.000193	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—prostate cancer	3.05e-05	0.000192	CcSEcCtD
Fosphenytoin—Decreased appetite—Prednisone—prostate cancer	3.04e-05	0.000192	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—prostate cancer	3.04e-05	0.000192	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—prostate cancer	3.03e-05	0.000191	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—prostate cancer	3.01e-05	0.00019	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—prostate cancer	3.01e-05	0.00019	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—prostate cancer	3.01e-05	0.00019	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—prostate cancer	3e-05	0.000189	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—prostate cancer	3e-05	0.000189	CcSEcCtD
Fosphenytoin—Constipation—Prednisone—prostate cancer	2.99e-05	0.000189	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—prostate cancer	2.98e-05	0.000188	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—prostate cancer	2.96e-05	0.000187	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—prostate cancer	2.95e-05	0.000186	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—prostate cancer	2.93e-05	0.000185	CcSEcCtD
Fosphenytoin—Asthenia—Docetaxel—prostate cancer	2.91e-05	0.000184	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—prostate cancer	2.91e-05	0.000183	CcSEcCtD
Fosphenytoin—Nausea—Etoposide—prostate cancer	2.9e-05	0.000183	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—prostate cancer	2.9e-05	0.000183	CcSEcCtD
Fosphenytoin—Feeling abnormal—Prednisone—prostate cancer	2.88e-05	0.000182	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—prostate cancer	2.88e-05	0.000182	CcSEcCtD
Fosphenytoin—Pruritus—Docetaxel—prostate cancer	2.87e-05	0.000181	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—prostate cancer	2.87e-05	0.000181	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—prostate cancer	2.86e-05	0.00018	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—prostate cancer	2.86e-05	0.00018	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—prostate cancer	2.85e-05	0.00018	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—prostate cancer	2.82e-05	0.000178	CcSEcCtD
Fosphenytoin—Asthenia—Capecitabine—prostate cancer	2.82e-05	0.000178	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—prostate cancer	2.8e-05	0.000177	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—prostate cancer	2.79e-05	0.000176	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—prostate cancer	2.79e-05	0.000176	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—prostate cancer	2.78e-05	0.000176	CcSEcCtD
Fosphenytoin—Urticaria—Prednisone—prostate cancer	2.78e-05	0.000175	CcSEcCtD
Fosphenytoin—Pruritus—Capecitabine—prostate cancer	2.78e-05	0.000175	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—prostate cancer	2.78e-05	0.000175	CcSEcCtD
Fosphenytoin—Diarrhoea—Docetaxel—prostate cancer	2.78e-05	0.000175	CcSEcCtD
Fosphenytoin—Body temperature increased—Prednisone—prostate cancer	2.77e-05	0.000175	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—prostate cancer	2.76e-05	0.000174	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—prostate cancer	2.74e-05	0.000173	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—prostate cancer	2.74e-05	0.000173	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—prostate cancer	2.73e-05	0.000172	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—prostate cancer	2.72e-05	0.000172	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—prostate cancer	2.71e-05	0.000171	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—prostate cancer	2.69e-05	0.00017	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—prostate cancer	2.69e-05	0.00017	CcSEcCtD
Fosphenytoin—Diarrhoea—Capecitabine—prostate cancer	2.69e-05	0.00017	CcSEcCtD
Fosphenytoin—Dizziness—Docetaxel—prostate cancer	2.68e-05	0.000169	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—prostate cancer	2.68e-05	0.000169	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—prostate cancer	2.68e-05	0.000169	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—prostate cancer	2.67e-05	0.000169	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—prostate cancer	2.65e-05	0.000167	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—prostate cancer	2.64e-05	0.000167	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—prostate cancer	2.64e-05	0.000167	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—prostate cancer	2.61e-05	0.000165	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—prostate cancer	2.61e-05	0.000165	CcSEcCtD
Fosphenytoin—Dizziness—Capecitabine—prostate cancer	2.6e-05	0.000164	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—prostate cancer	2.58e-05	0.000163	CcSEcCtD
Fosphenytoin—Vomiting—Docetaxel—prostate cancer	2.58e-05	0.000163	CcSEcCtD
Fosphenytoin—Rash—Docetaxel—prostate cancer	2.56e-05	0.000161	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—prostate cancer	2.56e-05	0.000161	CcSEcCtD
Fosphenytoin—Dermatitis—Docetaxel—prostate cancer	2.56e-05	0.000161	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—prostate cancer	2.55e-05	0.000161	CcSEcCtD
Fosphenytoin—Headache—Docetaxel—prostate cancer	2.54e-05	0.00016	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—prostate cancer	2.53e-05	0.00016	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—prostate cancer	2.52e-05	0.000159	CcSEcCtD
Fosphenytoin—Asthenia—Prednisone—prostate cancer	2.51e-05	0.000158	CcSEcCtD
Fosphenytoin—Vomiting—Capecitabine—prostate cancer	2.5e-05	0.000158	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.49e-05	0.000157	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—prostate cancer	2.49e-05	0.000157	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—prostate cancer	2.48e-05	0.000156	CcSEcCtD
Fosphenytoin—Rash—Capecitabine—prostate cancer	2.48e-05	0.000156	CcSEcCtD
Fosphenytoin—Pruritus—Prednisone—prostate cancer	2.48e-05	0.000156	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—prostate cancer	2.48e-05	0.000156	CcSEcCtD
Fosphenytoin—Dermatitis—Capecitabine—prostate cancer	2.48e-05	0.000156	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—prostate cancer	2.47e-05	0.000156	CcSEcCtD
Fosphenytoin—Headache—Capecitabine—prostate cancer	2.46e-05	0.000155	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—prostate cancer	2.46e-05	0.000155	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—prostate cancer	2.45e-05	0.000155	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—prostate cancer	2.44e-05	0.000154	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—prostate cancer	2.43e-05	0.000154	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—prostate cancer	2.41e-05	0.000152	CcSEcCtD
Fosphenytoin—Nausea—Docetaxel—prostate cancer	2.41e-05	0.000152	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—prostate cancer	2.41e-05	0.000152	CcSEcCtD
Fosphenytoin—Diarrhoea—Prednisone—prostate cancer	2.4e-05	0.000151	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—prostate cancer	2.38e-05	0.00015	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—prostate cancer	2.37e-05	0.000149	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—prostate cancer	2.34e-05	0.000148	CcSEcCtD
Fosphenytoin—Nausea—Capecitabine—prostate cancer	2.33e-05	0.000147	CcSEcCtD
Fosphenytoin—Dizziness—Prednisone—prostate cancer	2.31e-05	0.000146	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.31e-05	0.000146	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—prostate cancer	2.29e-05	0.000145	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—prostate cancer	2.27e-05	0.000144	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—prostate cancer	2.26e-05	0.000143	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—prostate cancer	2.26e-05	0.000142	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—prostate cancer	2.25e-05	0.000142	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—prostate cancer	2.23e-05	0.000141	CcSEcCtD
Fosphenytoin—Vomiting—Prednisone—prostate cancer	2.23e-05	0.00014	CcSEcCtD
Fosphenytoin—Rash—Prednisone—prostate cancer	2.21e-05	0.000139	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisone—prostate cancer	2.21e-05	0.000139	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—prostate cancer	2.2e-05	0.000139	CcSEcCtD
Fosphenytoin—Headache—Prednisone—prostate cancer	2.19e-05	0.000138	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—prostate cancer	2.17e-05	0.000137	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—prostate cancer	2.17e-05	0.000137	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—prostate cancer	2.16e-05	0.000137	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—prostate cancer	2.09e-05	0.000132	CcSEcCtD
Fosphenytoin—Nausea—Prednisone—prostate cancer	2.08e-05	0.000131	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—prostate cancer	2.01e-05	0.000127	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—prostate cancer	2e-05	0.000126	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—prostate cancer	1.96e-05	0.000124	CcSEcCtD
Fosphenytoin—Pruritus—Epirubicin—prostate cancer	1.94e-05	0.000122	CcSEcCtD
Fosphenytoin—Diarrhoea—Epirubicin—prostate cancer	1.87e-05	0.000118	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—prostate cancer	1.82e-05	0.000115	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—prostate cancer	1.81e-05	0.000114	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—prostate cancer	1.79e-05	0.000113	CcSEcCtD
Fosphenytoin—Vomiting—Epirubicin—prostate cancer	1.74e-05	0.00011	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—prostate cancer	1.73e-05	0.000109	CcSEcCtD
Fosphenytoin—Rash—Epirubicin—prostate cancer	1.73e-05	0.000109	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—prostate cancer	1.72e-05	0.000109	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—prostate cancer	1.72e-05	0.000108	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—prostate cancer	1.68e-05	0.000106	CcSEcCtD
Fosphenytoin—Nausea—Epirubicin—prostate cancer	1.63e-05	0.000103	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—prostate cancer	1.61e-05	0.000102	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—prostate cancer	1.6e-05	0.000101	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—prostate cancer	1.6e-05	0.000101	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—prostate cancer	1.59e-05	0.0001	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—prostate cancer	1.5e-05	9.49e-05	CcSEcCtD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.37e-06	4.99e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NQO1—prostate cancer	4.36e-06	4.97e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NQO1—prostate cancer	4.34e-06	4.94e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—COMT—prostate cancer	4.32e-06	4.92e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—TH—prostate cancer	4.3e-06	4.9e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTP1—prostate cancer	4.3e-06	4.9e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IL2—prostate cancer	4.28e-06	4.88e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—TH—prostate cancer	4.27e-06	4.87e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—TCN2—prostate cancer	4.27e-06	4.87e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—UCP3—prostate cancer	4.27e-06	4.87e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PDHA1—prostate cancer	4.27e-06	4.87e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA3—prostate cancer	4.27e-06	4.87e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ACHE—prostate cancer	4.27e-06	4.87e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTT1—prostate cancer	4.27e-06	4.87e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.27e-06	4.87e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP3A4—prostate cancer	4.25e-06	4.85e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.25e-06	4.84e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.23e-06	4.82e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP3A4—prostate cancer	4.23e-06	4.82e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ITPR1—prostate cancer	4.23e-06	4.82e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NCOA2—prostate cancer	4.23e-06	4.82e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP2A6—prostate cancer	4.22e-06	4.81e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.21e-06	4.8e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.21e-06	4.79e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP1B1—prostate cancer	4.18e-06	4.77e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP1B1—prostate cancer	4.16e-06	4.74e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—AKR1C3—prostate cancer	4.11e-06	4.68e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PRKACB—prostate cancer	4.09e-06	4.66e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.08e-06	4.65e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.08e-06	4.65e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GGT1—prostate cancer	4.05e-06	4.62e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP17A1—prostate cancer	4.04e-06	4.61e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SLC5A5—prostate cancer	4.03e-06	4.59e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GGT1—prostate cancer	4.03e-06	4.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—TYMS—prostate cancer	4e-06	4.55e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NCOA1—prostate cancer	3.99e-06	4.55e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.99e-06	4.55e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NCOA1—prostate cancer	3.97e-06	4.52e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTM1—prostate cancer	3.95e-06	4.5e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP2E1—prostate cancer	3.94e-06	4.49e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP19A1—prostate cancer	3.93e-06	4.48e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP19A1—prostate cancer	3.91e-06	4.46e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA4—prostate cancer	3.91e-06	4.45e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.91e-06	4.45e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NQO1—prostate cancer	3.89e-06	4.44e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—LPL—prostate cancer	3.88e-06	4.42e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NCOA2—prostate cancer	3.85e-06	4.39e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—EP300—prostate cancer	3.84e-06	4.38e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—TH—prostate cancer	3.84e-06	4.37e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.81e-06	4.35e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA2—prostate cancer	3.81e-06	4.34e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.8e-06	4.33e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—RXRA—prostate cancer	3.79e-06	4.33e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.78e-06	4.31e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—RXRA—prostate cancer	3.77e-06	4.3e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.76e-06	4.29e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCG5—prostate cancer	3.76e-06	4.29e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP1A1—prostate cancer	3.74e-06	4.27e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SRC—prostate cancer	3.74e-06	4.26e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP1B1—prostate cancer	3.73e-06	4.25e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ERCC2—prostate cancer	3.71e-06	4.23e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.69e-06	4.21e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.68e-06	4.19e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA1—prostate cancer	3.67e-06	4.19e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.67e-06	4.18e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—COMT—prostate cancer	3.66e-06	4.17e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VEGFA—prostate cancer	3.64e-06	4.15e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTP1—prostate cancer	3.64e-06	4.15e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—COMT—prostate cancer	3.63e-06	4.14e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.63e-06	4.14e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTO1—prostate cancer	3.63e-06	4.14e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NAT2—prostate cancer	3.63e-06	4.14e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTP1—prostate cancer	3.62e-06	4.12e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GGT1—prostate cancer	3.62e-06	4.12e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.59e-06	4.09e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ITPR1—prostate cancer	3.58e-06	4.08e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NCOA1—prostate cancer	3.56e-06	4.06e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ITPR1—prostate cancer	3.56e-06	4.06e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NQO1—prostate cancer	3.55e-06	4.05e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.52e-06	4.01e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP19A1—prostate cancer	3.51e-06	4e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.5e-06	3.99e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—TH—prostate cancer	3.5e-06	3.99e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—MTHFR—prostate cancer	3.49e-06	3.98e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PLCB2—prostate cancer	3.48e-06	3.97e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—LRP2—prostate cancer	3.48e-06	3.97e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.48e-06	3.97e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.48e-06	3.96e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.46e-06	3.95e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.44e-06	3.93e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PPARA—prostate cancer	3.42e-06	3.9e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—P4HB—prostate cancer	3.42e-06	3.89e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP1B1—prostate cancer	3.4e-06	3.88e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—RXRA—prostate cancer	3.39e-06	3.86e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—TYMS—prostate cancer	3.38e-06	3.86e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—TYMS—prostate cancer	3.36e-06	3.83e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTM1—prostate cancer	3.34e-06	3.81e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TGFB1—prostate cancer	3.34e-06	3.81e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTM1—prostate cancer	3.32e-06	3.79e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.32e-06	3.79e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GGT1—prostate cancer	3.3e-06	3.76e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.29e-06	3.75e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—LPL—prostate cancer	3.28e-06	3.74e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—LPL—prostate cancer	3.26e-06	3.72e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—COMT—prostate cancer	3.26e-06	3.72e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTP1—prostate cancer	3.25e-06	3.7e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NCOA1—prostate cancer	3.25e-06	3.7e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.24e-06	3.69e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CAV1—prostate cancer	3.22e-06	3.67e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.2e-06	3.65e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ITPR1—prostate cancer	3.2e-06	3.64e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MED12—prostate cancer	3.19e-06	3.63e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP1A1—prostate cancer	3.17e-06	3.61e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GNG5—prostate cancer	3.16e-06	3.6e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP1A1—prostate cancer	3.15e-06	3.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ERCC2—prostate cancer	3.14e-06	3.58e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.14e-06	3.58e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ERCC2—prostate cancer	3.13e-06	3.56e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—KRAS—prostate cancer	3.1e-06	3.53e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—RXRA—prostate cancer	3.09e-06	3.52e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOA3—prostate cancer	3.04e-06	3.47e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—TYMS—prostate cancer	3.02e-06	3.44e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3e-06	3.42e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTM1—prostate cancer	2.98e-06	3.4e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—COMT—prostate cancer	2.97e-06	3.39e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTP1—prostate cancer	2.96e-06	3.37e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—MTHFR—prostate cancer	2.95e-06	3.37e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—MTHFR—prostate cancer	2.94e-06	3.35e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.93e-06	3.34e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—LPL—prostate cancer	2.93e-06	3.34e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ITPR1—prostate cancer	2.91e-06	3.32e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HPGDS—prostate cancer	2.9e-06	3.31e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PPARA—prostate cancer	2.9e-06	3.3e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.89e-06	3.29e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PPARA—prostate cancer	2.88e-06	3.29e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.86e-06	3.27e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CA—prostate cancer	2.84e-06	3.24e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.83e-06	3.22e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTT1—prostate cancer	2.82e-06	3.21e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ACHE—prostate cancer	2.82e-06	3.21e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ERCC2—prostate cancer	2.81e-06	3.2e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.78e-06	3.17e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—INS—prostate cancer	2.78e-06	3.16e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—TYMS—prostate cancer	2.75e-06	3.14e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TP53—prostate cancer	2.75e-06	3.14e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CAV1—prostate cancer	2.73e-06	3.11e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTM1—prostate cancer	2.72e-06	3.1e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CREBBP—prostate cancer	2.72e-06	3.1e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CAV1—prostate cancer	2.71e-06	3.09e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.71e-06	3.09e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PRKACB—prostate cancer	2.69e-06	3.07e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—LPL—prostate cancer	2.67e-06	3.04e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.67e-06	3.04e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—MTHFR—prostate cancer	2.64e-06	3.01e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.6e-06	2.97e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.59e-06	2.95e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PPARA—prostate cancer	2.59e-06	2.95e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.58e-06	2.94e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CD—prostate cancer	2.58e-06	2.94e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ERCC2—prostate cancer	2.56e-06	2.92e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOA2—prostate cancer	2.54e-06	2.9e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.48e-06	2.83e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CG—prostate cancer	2.47e-06	2.81e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NOS3—prostate cancer	2.43e-06	2.77e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CAV1—prostate cancer	2.43e-06	2.77e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.42e-06	2.76e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—MTHFR—prostate cancer	2.4e-06	2.74e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.37e-06	2.7e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PPARA—prostate cancer	2.36e-06	2.69e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—INS—prostate cancer	2.35e-06	2.68e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NQO1—prostate cancer	2.34e-06	2.67e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—INS—prostate cancer	2.34e-06	2.66e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.32e-06	2.65e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—AKT1—prostate cancer	2.32e-06	2.65e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—TH—prostate cancer	2.31e-06	2.63e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CREBBP—prostate cancer	2.3e-06	2.62e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CREBBP—prostate cancer	2.29e-06	2.61e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CB—prostate cancer	2.25e-06	2.56e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTGS2—prostate cancer	2.23e-06	2.54e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CAV1—prostate cancer	2.22e-06	2.53e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.22e-06	2.53e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CD—prostate cancer	2.18e-06	2.49e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GGT1—prostate cancer	2.17e-06	2.48e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CD—prostate cancer	2.17e-06	2.47e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOA1—prostate cancer	2.14e-06	2.44e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.12e-06	2.42e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.11e-06	2.41e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—INS—prostate cancer	2.1e-06	2.39e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NOS3—prostate cancer	2.06e-06	2.35e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CREBBP—prostate cancer	2.05e-06	2.34e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NOS3—prostate cancer	2.05e-06	2.34e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—RXRA—prostate cancer	2.04e-06	2.32e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.02e-06	2.3e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—COMT—prostate cancer	1.96e-06	2.24e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTP1—prostate cancer	1.95e-06	2.23e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.95e-06	2.22e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTEN—prostate cancer	1.94e-06	2.21e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ITPR1—prostate cancer	1.92e-06	2.19e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—INS—prostate cancer	1.91e-06	2.18e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.9e-06	2.17e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CB—prostate cancer	1.89e-06	2.16e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTGS2—prostate cancer	1.88e-06	2.15e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTGS2—prostate cancer	1.87e-06	2.14e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CREBBP—prostate cancer	1.87e-06	2.14e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—EP300—prostate cancer	1.85e-06	2.11e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NOS3—prostate cancer	1.84e-06	2.1e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—TYMS—prostate cancer	1.82e-06	2.07e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTM1—prostate cancer	1.79e-06	2.05e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.78e-06	2.02e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—LPL—prostate cancer	1.76e-06	2.01e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.7e-06	1.94e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.7e-06	1.94e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ERCC2—prostate cancer	1.69e-06	1.92e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTGS2—prostate cancer	1.68e-06	1.92e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NOS3—prostate cancer	1.68e-06	1.91e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTEN—prostate cancer	1.64e-06	1.87e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTEN—prostate cancer	1.63e-06	1.86e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MTHFR—prostate cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—EP300—prostate cancer	1.57e-06	1.79e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—EP300—prostate cancer	1.56e-06	1.78e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PPARA—prostate cancer	1.56e-06	1.77e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.55e-06	1.76e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTGS2—prostate cancer	1.53e-06	1.75e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTEN—prostate cancer	1.47e-06	1.67e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CAV1—prostate cancer	1.46e-06	1.67e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—EP300—prostate cancer	1.4e-06	1.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.37e-06	1.56e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTEN—prostate cancer	1.34e-06	1.52e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.33e-06	1.52e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—EP300—prostate cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—INS—prostate cancer	1.26e-06	1.44e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CREBBP—prostate cancer	1.24e-06	1.41e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.17e-06	1.34e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.16e-06	1.32e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CA—prostate cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—AKT1—prostate cancer	1.12e-06	1.28e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NOS3—prostate cancer	1.11e-06	1.26e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.04e-06	1.18e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.02e-06	1.16e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTGS2—prostate cancer	1.01e-06	1.15e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—AKT1—prostate cancer	9.47e-07	1.08e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CA—prostate cancer	9.44e-07	1.08e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—AKT1—prostate cancer	9.42e-07	1.07e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTEN—prostate cancer	8.82e-07	1.01e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—AKT1—prostate cancer	8.46e-07	9.64e-06	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—EP300—prostate cancer	8.41e-07	9.59e-06	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—AKT1—prostate cancer	7.71e-07	8.79e-06	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.22e-07	7.09e-06	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—AKT1—prostate cancer	5.08e-07	5.8e-06	CbGpPWpGaD
